This guy Martin Shekryl is nothing but a phony and a blogger with no relevant experience or knowledge to comment such things.There are several holes in his story here are just a few.
*Revascor is a drug (false)
*patients followed up for 6 months(false patients had actually been followed up for median of 18 months)
*4.4 % of revascor patients died at 6 months( false death from cardiac causes was zero over the period)
* he also mentions his team reviewed quite a few CHF studies and the results were similar however no companies, trials or dates are mentioned.
*he also values MSB entirely on CHF and 50% of that for to cephalon whileconvenently forgetting about the other 9 and counting, multi billion dollar aplictions now underway or nearing human trials.
I could go on but follow the link below to find some interesting information on the author Martin Shekrel and
the lack of knowledge and qualifications this blatant downramper has.
https://sites.google.com/site/vatsire/Searching-for-Martin-Shkreli
- Forums
- ASX - By Stock
- MSB
- seekingalpha comments
seekingalpha comments, page-7
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
91.5¢ |
Change
-0.010(1.08%) |
Mkt cap ! $1.044B |
Open | High | Low | Value | Volume |
94.0¢ | 94.0¢ | 91.5¢ | $1.609M | 1.737M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 131951 | 91.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.5¢ | 22000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 128465 | 0.915 |
9 | 161264 | 0.910 |
4 | 35395 | 0.905 |
27 | 200171 | 0.900 |
2 | 6574 | 0.895 |
Price($) | Vol. | No. |
---|---|---|
0.925 | 22000 | 1 |
0.930 | 86289 | 4 |
0.935 | 66195 | 6 |
0.940 | 33109 | 3 |
0.945 | 76928 | 3 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |